TW340841B - Process for the preparation of ropivacaine hydrochloride monohydrate - Google Patents

Process for the preparation of ropivacaine hydrochloride monohydrate

Info

Publication number
TW340841B
TW340841B TW085105371A TW85105371A TW340841B TW 340841 B TW340841 B TW 340841B TW 085105371 A TW085105371 A TW 085105371A TW 85105371 A TW85105371 A TW 85105371A TW 340841 B TW340841 B TW 340841B
Authority
TW
Taiwan
Prior art keywords
formula
product
salt
extraction
water
Prior art date
Application number
TW085105371A
Other languages
English (en)
Inventor
Jaksch Peter
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Application granted granted Critical
Publication of TW340841B publication Critical patent/TW340841B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00—Separation of optically-active compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Saccharide Compounds (AREA)
TW085105371A 1995-05-16 1996-05-06 Process for the preparation of ropivacaine hydrochloride monohydrate TW340841B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9501808A SE9501808D0 (sv) 1995-05-16 1995-05-16 New process

Publications (1)

Publication Number Publication Date
TW340841B true TW340841B (en) 1998-09-21

Family

ID=20398325

Family Applications (1)

Application Number Title Priority Date Filing Date
TW085105371A TW340841B (en) 1995-05-16 1996-05-06 Process for the preparation of ropivacaine hydrochloride monohydrate

Country Status (34)

Country Link
US (1) US5959112A (zh)
EP (1) EP0828711B1 (zh)
JP (1) JP3079112B2 (zh)
KR (1) KR100425232B1 (zh)
CN (1) CN1121388C (zh)
AR (1) AR002737A1 (zh)
AT (1) ATE207900T1 (zh)
AU (1) AU696875B2 (zh)
BR (1) BR9608820A (zh)
CA (1) CA2219308C (zh)
CZ (1) CZ290576B6 (zh)
DE (1) DE69616543T2 (zh)
DK (1) DK0828711T3 (zh)
EE (1) EE03394B1 (zh)
ES (1) ES2166888T3 (zh)
HK (1) HK1009805A1 (zh)
HU (1) HU221793B1 (zh)
IL (1) IL118178A (zh)
IN (1) IN185146B (zh)
IS (1) IS1832B (zh)
MY (1) MY115018A (zh)
NO (1) NO309035B1 (zh)
NZ (1) NZ308249A (zh)
PL (1) PL184767B1 (zh)
PT (1) PT828711E (zh)
RU (1) RU2167153C2 (zh)
SA (1) SA96160764B1 (zh)
SE (1) SE9501808D0 (zh)
SK (1) SK281812B6 (zh)
TR (1) TR199701362T1 (zh)
TW (1) TW340841B (zh)
UA (1) UA46770C2 (zh)
WO (1) WO1996036606A1 (zh)
ZA (1) ZA963545B (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69824632T2 (de) 1997-11-12 2005-06-09 Mitsubishi Chemical Corp. Purinderivate und medikamente, welche dieselben als aktiven bestandteil enthalten
AU4319000A (en) 1999-05-11 2000-11-21 Mitsubishi Chemical Corporation Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof
WO2001029002A1 (en) * 1999-10-20 2001-04-26 Smithkline Beecham Plc Process for the preparation of 4-(fluorophenyl)piperidine esters
BRPI0104491B8 (pt) * 2001-10-10 2021-05-25 Cristalia Produtos Quim Farmaceuticos Ltda n-(2,6-dimetilfenil)-1-propil-2-piperidinocarboxamida; processo de obtenção dos enantiômeros; mistura não racêmica dos anantiômeros e seu processo de obtenção e composição farmacêutica.
US20060270708A1 (en) * 2005-05-25 2006-11-30 Navinta Llc Novel process for preparation of isotonic aqueous injection of ropivacaine
WO2009044404A1 (en) * 2007-10-01 2009-04-09 Ramniwas Goel Process for the preparation of (s)-ropivacaine hydrochloride monohydrate
CN102093284B (zh) * 2010-12-29 2013-05-08 宜昌人福药业有限责任公司 富集哌啶-2-甲酰苯胺类旋光化合物的方法
WO2014009964A1 (en) * 2012-07-11 2014-01-16 Neon Laboratories Limited Process for enantiomeric enrichment of 2 ', 6 ' - pipecoloxylidide
CN103086954A (zh) * 2013-02-04 2013-05-08 山东省医药工业研究所 一种制备罗哌卡因的方法
CN104003930B (zh) * 2014-06-13 2016-06-08 山东金诃药物研究开发有限公司 一种盐酸罗哌卡因的制备方法
CN113105386B (zh) * 2021-04-10 2022-11-25 河北一品制药股份有限公司 一种盐酸罗哌卡因一水合物工业化的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE341404B (zh) * 1967-05-18 1971-12-27 Sterling Drug Inc
WO1985000599A1 (en) * 1983-08-01 1985-02-14 A/S Apothekernes Laboratorium For Specialpraeparat L-N-n-PROPYLPIPECOLIC ACID-2,6-XYLIDIDE AND METHOD FOR PREPARING THE SAME
SE451840B (sv) * 1986-01-03 1987-11-02 Astra Laekemedel Ab Optiskt rent monohydrat av s-(-)-1-propyl-2',6'-pipekoloxylididhydroklorid, sett att framstella denna och farmaceutiska beredningar for lokalbedovning

Also Published As

Publication number Publication date
CA2219308A1 (en) 1996-11-21
HUP9900327A2 (hu) 1999-05-28
KR100425232B1 (ko) 2004-05-20
EP0828711B1 (en) 2001-10-31
CN1189822A (zh) 1998-08-05
IL118178A (en) 2003-07-31
JP3079112B2 (ja) 2000-08-21
NO975220L (no) 1997-11-13
PL323461A1 (en) 1998-03-30
DE69616543T2 (de) 2002-06-27
DE69616543D1 (de) 2001-12-06
CN1121388C (zh) 2003-09-17
IN185146B (zh) 2000-11-25
AR002737A1 (es) 1998-04-29
ES2166888T3 (es) 2002-05-01
HU221793B1 (hu) 2003-01-28
AU696875B2 (en) 1998-09-17
NO309035B1 (no) 2000-12-04
SK281812B6 (sk) 2001-08-06
MY115018A (en) 2003-03-31
UA46770C2 (uk) 2002-06-17
CZ290576B6 (cs) 2002-08-14
CZ345297A3 (cs) 1998-03-18
EE03394B1 (et) 2001-04-16
SK151297A3 (en) 1998-05-06
DK0828711T3 (da) 2002-02-11
PT828711E (pt) 2002-04-29
ATE207900T1 (de) 2001-11-15
US5959112A (en) 1999-09-28
IL118178A0 (en) 1996-09-12
TR199701362T1 (xx) 1998-05-21
PL184767B1 (pl) 2002-12-31
RU2167153C2 (ru) 2001-05-20
EE9700301A (et) 1998-06-15
ZA963545B (en) 1996-11-18
HK1009805A1 (en) 1999-06-11
HUP9900327A3 (en) 2001-05-28
SA96160764B1 (ar) 2006-07-30
JPH11505242A (ja) 1999-05-18
CA2219308C (en) 2007-12-18
IS1832B (is) 2002-10-30
NZ308249A (en) 1998-08-26
AU5783296A (en) 1996-11-29
EP0828711A1 (en) 1998-03-18
NO975220D0 (no) 1997-11-13
KR19990014827A (ko) 1999-02-25
WO1996036606A1 (en) 1996-11-21
BR9608820A (pt) 1999-06-15
IS4607A (is) 1997-11-04
SE9501808D0 (sv) 1995-05-16

Similar Documents

Publication Publication Date Title
TW340841B (en) Process for the preparation of ropivacaine hydrochloride monohydrate
CA2083605A1 (en) Method for synthesis of omeprazole
EP1226123A1 (en) Cyano compounds as factor xa inhibitors
MY109335A (en) Continous process for the production of methionine or methionine derivatives
Rothschild et al. Synthesis and metabolism of a histamine metabolite, 1-methyl-4-(β-aminoethyl)-imidazole
AU2482500A (en) Synthesis of histamine dihydrochloride
ATE367851T1 (de) Rückgewinnungsverfahren für flüchtige verbindungen aus feststoffenthaltenden wässrigen lösungen
US6586418B2 (en) Thrombin or factor Xa inhibitors
HU901346D0 (en) Process for preparation of n-acetyl-neuraminic acid sodium salt trihydrate
RU97120751A (ru) Способ получения моногидрата ропивакаина гидрохлорида и моногидрат ропивакаина гидрохлорида, полученный этим способом
UA41902C2 (uk) Спосіб одержання дигідрохлориду азитроміцину
Grieco et al. 2-Azonianorbornene-2-spiro-1′-aziridinium triflate-a novel ethylene immonium ion equivalent: Application to a synthesis of physostigmine
US6407256B1 (en) Cyano-pyrrole, cyano-imidazole, cyano-pyrazole, and cyano-triazole compounds as factor Xa inhibitors
RU2144026C1 (ru) Способ получения r(+)-1,2,3,6-тетрагидро-4-фенил-1-[(3-фенил-3-циклогексен-1-ил)метил]пирид ина или его фармацевтически приемлемых солей, промежуточные вещества и способы их получения
MX9707550A (es) Procedimiento para la recuperacion de ampicilina.
TH29320B (th) กรรมวิธีใหม่สำหรับการเตรียมโรพิแวคเคน ไฮโดรคลอไรด์โมโนไฮเดรต
TH27327A (th) กรรมวิธีใหม่สำหรับการเตรียมโรพิแวคเคน ไฮโดรคลอไรด์โมโนไฮเดรต
Ecke Synthesis of glucosides of isopropyl-3-chlorocarbanilate metabolites
CH648566A5 (it) Procedimento per la eliminazione del gruppo n-formile da peptidi n-formilati e da esteri di peptidi n-formilati.
EP1072585A3 (en) Process for producing dimethylcyanamide
Nilsson et al. An improved synthesis of the enantiomers of bm‐5 and their effects on the central in vivo release of acetylcholine
KR970002912B1 (ko) 팔라듐 촉매를 이용한 아프파탐의 제조방법
CA2069352A1 (en) Method of preparing .alpha.-l-aspartyl-l-phenylalaline methyl ester hydrochloride
AU2013205836A1 (en) Processes for preparing morphinan-6-one products with low levels of alpha, beta-unsaturated ketone compounds
Ley et al. The use of polymer-assisted solution-phase synthesis and automation for the high-throughput preparation of biologically active compounds

Legal Events

Date Code Title Description
MK4A Expiration of patent term of an invention patent